New product uses parametric imaging to give more infomation than DSA alone
GE Healthcare has recieved FDA clearance of AngioViz, an application that gives doctors a new visualization of vascular flow on a single image, helpful during complex interventional radiology procedures.
AngioViz provides a new visualization of the vascular flow seen in Digital Subtraction Angiography (DSA) imaging utilizing a technique called parametric imaging. AngioViz looks at each pixel in the image series and determines two things-the peak value of opacification caused by the contrast, and the time it takes for that pixel to reach peak opacification. These two parameters can be displayed as separate images or combined into a single color-coded image that represents parameters of vascular flow. This enables doctors to perceive parameters of flow quickly to support decision-making. In addition, AngioViz allows easy comparison of parametric images from different DSA acquisitions, such as pre- and post-treatment images. This can help physicians understand the impact on flow dynamics of various interventional treatments.
AngioViz bold flow visualization has the potential to be applied to a variety of clinical situations
· Help see where a blocked artery diminishes blood flow in the brain or other tissue
· Identify the timing and amount of blood flow in abnormal vessel anatomy
· Observe flow in abnormal tissue before and after treatment to support interventional oncology treatment
· Visualize peripheral artery blood flow before and after balloon angioplasty and stenting
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.
Could a Newly FDA-Cleared C-Arm Device Bolster Efficiency for Interventional Radiologists?
April 22nd 2024In addition to advanced imaging quality and dose efficiency, the Philips Zenition 30 mobile C-arm device emphasizes personalized user profiles and automated customization to help reduce procedure time.